-transparent.png){kind=logo}
IgG and IgM class insulin autoantibodies were measured by an enzyme-linked immunosorbent assay in sera from members of the Barts-Windsor-Middlesex prospective family study for Type 1 (insulin-dependent) diabetes. One hundred and twelve individuals from 28 families were selected for study on the basis of a clearly defined islet cell antibody status. IgG insulin autoantibodies were found to be significantly associated with islet cell antibody positive (n = 30) versus islet cell antibody negative (n = 57) first degree family relatives (p = 0.002), with increased significance (p = 0.0003) if complement-fixing (CF)-islet cell antibody individuals (n = 20) only were considered. In addition, a significant association of IgG insulin autoantibodies with subsequent development of diabetes was observed within the CF-islet cell antibody positive group (p less than 0.0003). No such associations were found for IgM insulin autoantibodies, but a higher prevalence of these autoantibodies was observed in islet cell antibody negative first degree relatives (n = 57) compared with a control group of 73 Blood Bank donors (p = 0.00007), and they were significantly associated with siblings (n = 48) rather than parents (n = 39), (p = 0.001). We conclude that the presence of IgG insulin autoantibodies and CF-islet cell antibodies confer more risk for future development of diabetes than the presence of either marker alone.
B M Dean, and
F Becker, and
J M McNally, and
A C Tarn, and
G Schwartz, and
E A Gale, and
G F Bottazzo
September 1990,
Clinical and experimental immunology,
B M Dean, and
F Becker, and
J M McNally, and
A C Tarn, and
G Schwartz, and
E A Gale, and
G F Bottazzo
August 1987,
Clinical and experimental immunology,
B M Dean, and
F Becker, and
J M McNally, and
A C Tarn, and
G Schwartz, and
E A Gale, and
G F Bottazzo
October 1990,
Zhonghua nei ke za zhi,
B M Dean, and
F Becker, and
J M McNally, and
A C Tarn, and
G Schwartz, and
E A Gale, and
G F Bottazzo
September 1988,
Diabetologia,
B M Dean, and
F Becker, and
J M McNally, and
A C Tarn, and
G Schwartz, and
E A Gale, and
G F Bottazzo
January 1999,
Autoimmunity,
B M Dean, and
F Becker, and
J M McNally, and
A C Tarn, and
G Schwartz, and
E A Gale, and
G F Bottazzo
May 1988,
Diabetologia,
B M Dean, and
F Becker, and
J M McNally, and
A C Tarn, and
G Schwartz, and
E A Gale, and
G F Bottazzo
January 1996,
Jornal de pediatria,
B M Dean, and
F Becker, and
J M McNally, and
A C Tarn, and
G Schwartz, and
E A Gale, and
G F Bottazzo
July 1994,
Diabetic medicine : a journal of the British Diabetic Association,
B M Dean, and
F Becker, and
J M McNally, and
A C Tarn, and
G Schwartz, and
E A Gale, and
G F Bottazzo
October 1985,
The New England journal of medicine,
B M Dean, and
F Becker, and
J M McNally, and
A C Tarn, and
G Schwartz, and
E A Gale, and
G F Bottazzo
December 1986,
Lancet (London, England),
